SUPPLEMENT

Q4 2020 — Condensed Consolidated Statement of Earnings

Q4 2020PDF · 2 pages21 KB
Johnson & Johnson and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited; in Millions Except Per Share Figures)
Percent
Percent 	Percent 	Increase
Amount 	to Sales 	Amount 	to Sales 	(Decrease)
Sales to customers 	22,475	$ 	100.0 	20,747	$ 	100.0 	8.3
Cost of products sold 	7,814 	34.8 	7,134 	34.4 	9.5
Gross Profit 	14,661 	65.2 	13,613 	65.6 	7.7
Selling, marketing and administrative expenses 	6,457 	28.7 	6,039 	29.1 	6.9
Research and development expense 	4,032 	17.9 	3,232 	15.6 	24.8
In-process research and development 	37 	0.2 	- 	-
Interest (income) expense, net 	74 	0.3 	4 	0.0
Other (income) expense, net 	2,354 	10.5 	16 	0.1
Restructuring 	60 	0.3 	104 	0.5
Earnings before provision for taxes on income 	1,647 	7.3 	4,218 	20.3 	(61.0)
Provision for/(Benefit from) taxes on income 	(91) 	(0.4) 	208 	1.0 	(143.8)
Net earnings 	1,738	$ 	7.7 	4,010	$ 	19.3 	(56.7)
Net earnings per share (Diluted) 	0.65	$ 	1.50	$ 	(56.7)
Average shares outstanding (Diluted) 	2,669.2 	2,669.1
Effective tax rate 	(5.5) % 	4.9 %
Adjusted earnings before provision for taxes and net earnings (1)
Earnings before provision for taxes on income 	5,601	$ 	24.9 	5,628	$ 	27.1 	(0.5)
Net earnings 	4,965	$ 	22.1 	5,027	$ 	24.2 	(1.2)
Net earnings per share (Diluted) 	1.86	$ 	1.88	$ 	(1.1)
Effective tax rate 	11.4 % 	10.7 %
(1) See Reconciliation of Non-GAAP Financial Measures.
FOURTH QUARTER
2020 	2019

-- 1 of 2 --

Johnson & Johnson and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited; in Millions Except Per Share Figures)
Percent
Percent 	Percent 	Increase
Amount 	to Sales 	Amount 	to Sales 	(Decrease)
Sales to customers 	82,584	$ 	100.0 	82,059	$ 	100.0 	0.6
Cost of products sold 	28,427 	34.4 	27,556 	33.6 	3.2
Gross Profit 	54,157 	65.6 	54,503 	66.4 	(0.6)
Selling, marketing and administrative expenses 	22,084 	26.8 	22,178 	27.0 	(0.4)
Research and development expense 	12,159 	14.7 	11,355 	13.8 	7.1
In-process research and development 	181 	0.2 	890 	1.1
Interest (income) expense, net 	90 	0.1 	(39) 	0.0
Other (income) expense, net 	2,899 	3.5 	2,525 	3.1
Restructuring 	247 	0.3 	266 	0.3
Earnings before provision for taxes on income 	16,497 	20.0 	17,328 	21.1 	(4.8)
Provision for taxes on income 	1,783 	2.2 	2,209 	2.7 	(19.3)
Net earnings 	14,714	$ 	17.8 	15,119	$ 	18.4 	(2.7)
Net earnings per share (Diluted) 	5.51	$ 	5.63	$ 	(2.1)
Average shares outstanding (Diluted) 	2,670.7 	2,684.3
Effective tax rate 	10.8 % 	12.7 %
Adjusted earnings before provision for taxes and net earnings (1)
Earnings before provision for taxes on income 	25,428	$ 	30.8 	28,225	$ 	34.4 	(9.9)
Net earnings 	21,433	$ 	26.0 	23,310	$ 	28.4 	(8.1)
Net earnings per share (Diluted) 	8.03	$ 	8.68	$ 	(7.5)
Effective tax rate 	15.7 % 	17.4 %
(1) See Reconciliation of Non-GAAP Financial Measures.
TWELVE MONTHS
2020 	2019

-- 2 of 2 --